This invention relates to biologically active polypeptides derived from
the E peptide that forms the C-terminus of the insulin-like growth factor
I (IGF-I) splice variant known as mechano growth factor (MGF). These
peptides are modified to improve their stability compared to the
naturally occurring E peptide.